Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
AACR Annual Meeting 2026 · San Diego, CA
19 shown of 9,672 total abstracts
  1. Abstract LBA4000LBA2026-04-01 · 15:45 CT · S406
    IMpower-10: Tecentriq (atezolizumab) 3L+ in NSCLC
    S. Modi, H. Rugo, M. Reck, et al. · Institut Gustave Roussy
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  2. Abstract LBA4001LBA2026-04-04 · 18:30 CT · E450
    FLAURA-877: Tagrisso (osimertinib) neoadjuvant in NSCLC
    S. Peters, C. Robert, T. Mok · Dana-Farber Cancer Institute
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  3. Abstract LBA4002LBA2026-04-03 · 20:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-279 study)
    A. Spira, M. Krop, M. Reck · Dana-Farber Cancer Institute
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  4. Abstract LBA4003LBA2026-04-04 · 21:00 CT · Hall B1
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-544 study)
    J. Brahmer, E. Winer, J. Cortes, et al. · Chinese University of Hong Kong
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  5. Abstract LBA4004LBA2026-04-01 · 18:15 CT · Arie Crown Theater
    Real-world effectiveness of Imfinzi vs standard of care in NSCLC
    H. Borghaei, S. Tolaney, S. Modi · Princess Margaret Cancer Centre
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  6. Abstract LBA4005LBA2026-04-05 · 13:15 CT · S406
    PACIFIC-623: Imfinzi (durvalumab) 3L+ in SCLC
    M. Reck, T. Mok · UCSF Helen Diller Family Comprehensive Cancer Center
    Plenary SessionLung Cancer—Small Cell📄🖼️
  7. Abstract LBA4006LBA2026-04-03 · 14:30 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-593
    H. Borghaei, H. Rugo, A. Spira · Royal Marsden Hospital
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  8. Abstract LBA4007LBA2026-04-02 · 20:45 CT · E450
    Long-term follow-up of Imfinzi adjuvant for NSCLC: PACIFIC-633
    S. Antonia, S. Peters, C. Saura · MD Anderson Cancer Center
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  9. Abstract LBA4008LBA2026-04-01 · 21:00 CT · Hall B1
    Long-term follow-up of Tagrisso 2L for NSCLC: FLAURA-657
    H. Rugo, J. Brahmer · Institut Gustave Roussy
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  10. Abstract LBA4009LBA2026-04-03 · 16:30 CT · S406
    CheckMate-111: Opdivo (nivolumab) 2L in NSCLC
    C. Robert, S. Modi, F. Andre, et al. · Massachusetts General Hospital
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  11. Abstract LBA4010LBA2026-04-01 · 21:30 CT · Arie Crown Theater
    Long-term follow-up of Imfinzi neoadjuvant for SCLC: PACIFIC-395
    E. Winer, J. Brahmer · Peter MacCallum Cancer Centre
    Plenary SessionLung Cancer—Small Cell📄🖼️
  12. Abstract LBA4011LBA2026-04-03 · 13:00 CT · Hall B1
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-860 study)
    G. Curigliano, S. Tolaney, J. Cortes, et al. · Institut Gustave Roussy
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  13. Abstract LBA4012LBA2026-04-05 · 21:15 CT · S100A
    Real-world effectiveness of Imfinzi vs standard of care in SCLC
    P. Schmid, S. Modi, H. Rugo, et al. · Cleveland Clinic
    Plenary SessionLung Cancer—Small Cell📄🖼️
  14. Abstract LBA4013LBA2026-04-02 · 13:30 CT · Arie Crown Theater
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-274
    M. Krop, H. Borghaei, E. Winer, et al. · Institut Gustave Roussy
    Plenary SessionLung Cancer—Small Cell📄🖼️
  15. Abstract LBA4014LBA2026-04-05 · 14:30 CT · S406
    FLAURA-10: Tagrisso (osimertinib) adjuvant in NSCLC
    N. Rizvi, R. Herbst · Mayo Clinic
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  16. Abstract LBA4015LBA2026-04-05 · 13:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-84 study)
    S. Peters, S. Modi, C. Saura, et al. · Chinese University of Hong Kong
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  17. Abstract LBA4016LBA2026-04-03 · 16:30 CT · Arie Crown Theater
    FLAURA-500: Tagrisso (osimertinib) 2L in NSCLC
    R. Herbst, C. Robert, F. Andre, et al. · University of Chicago
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  18. Abstract LBA4017LBA2026-04-01 · 20:45 CT · E450
    Long-term follow-up of Tagrisso maintenance for NSCLC: FLAURA-926
    R. Herbst, H. Rugo, P. Schmid · Memorial Sloan Kettering Cancer Center
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  19. Abstract LBA4018LBA2026-04-04 · 14:30 CT · Hall B1
    Long-term follow-up of Imfinzi 2L for NSCLC: PACIFIC-166
    S. Peters, L. Paz-Ares · Johns Hopkins Kimmel Cancer Center
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.